NCT06265870View on ClinicalTrials.gov

Specific Versus Empirical Anthelminthic Treatment in Eosinophilia

NARecruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Eosinophilia
Interventions
DRUG

Albendazole

Participants receive empiric anthelminthic treatment which is albendazole 400 mg twice a day for seven consecutive days

DRUG

Ivermectin or albendazole

Participants will receive specific anthelminthic treatment tailored to the results of the stool tests

Trial Locations (1)

90110

RECRUITING

Prince of Songkla University - Hat Yai Campus: Prince of Songkla University, Hat Yai

All Listed Sponsors
lead

Prince of Songkla University

OTHER